| Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents LR Chiarelli, M Mori, D Barlocco, G Beretta, A Gelain, E Pini, M Porcino, ... European journal of medicinal chemistry 155, 754-763, 2018 | 66 | 2018 |
| New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents LR Chiarelli, M Mori, G Beretta, A Gelain, E Pini, JC Sammartino, ... Journal of Enzyme Inhibition and Medicinal Chemistry 34 (1), 823-828, 2019 | 32 | 2019 |
| Multitargeting compounds: a promising strategy to overcome multi-drug resistant tuberculosis G Stelitano, JC Sammartino, LR Chiarelli Molecules 25 (5), 1239, 2020 | 30 | 2020 |
| Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design M Mori, G Stelitano, A Gelain, E Pini, LR Chiarelli, JC Sammartino, G Poli, ... Journal of Medicinal Chemistry 63 (13), 7066-7080, 2020 | 24 | 2020 |
| Synthesis, characterization, and biological evaluation of new derivatives targeting MbtI as antitubercular agents M Mori, G Stelitano, LR Chiarelli, G Cazzaniga, A Gelain, D Barlocco, ... Pharmaceuticals 14 (2), 155, 2021 | 23 | 2021 |
| Towards real-time and affordable strain-level metagenomics-based foodborne outbreak investigations using Oxford nanopore sequencing technologies FE Buytaers, A Saltykova, S Denayer, B Verhaegen, K Vanneste, ... Frontiers in Microbiology 12, 738284, 2021 | 21 | 2021 |
| Structural and activity relationships of 6-sulfonyl-8-nitrobenzothiazinones as antitubercular agents D Fan, B Wang, G Stelitano, K Savková, R Shi, S Huszár, Q Han, ... Journal of Medicinal Chemistry 64 (19), 14526-14539, 2021 | 18 | 2021 |
| Synthesis and assessment of the in vitro and ex vivo activity of salicylate synthase (Mbti) inhibitors as new candidates for the treatment of mycobacterial infections M Mori, G Stelitano, A Griego, LR Chiarelli, G Cazzaniga, A Gelain, E Pini, ... Pharmaceuticals 15 (8), 992, 2022 | 14 | 2022 |
| Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent G Cazzaniga, M Mori, F Meneghetti, LR Chiarelli, G Stelitano, I Caligiuri, ... European Journal of Medicinal Chemistry 234, 114235, 2022 | 11 | 2022 |
| Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options D Recchia, G Stelitano, A Stamilla, DL Gutierrez, G Degiacomi, ... International Journal of Molecular Sciences 24 (5), 4635, 2023 | 10 | 2023 |
| The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme JM Ezquerra-Aznárez, G Degiacomi, H Gašparovič, G Stelitano, ... International Journal of Molecular Sciences 23 (2), 771, 2022 | 10 | 2022 |
| Iron acquisition and metabolism as a promising target for antimicrobials (bottlenecks and opportunities): where do we stand? G Stelitano, M Cocorullo, M Mori, S Villa, F Meneghetti, LR Chiarelli International Journal of Molecular Sciences 24 (7), 6181, 2023 | 9 | 2023 |
| Development of 6-methanesulfonyl-8-nitrobenzothiazinone based antitubercular agents R Shi, B Wang, G Stelitano, X Wu, Y Shan, Y Wu, X Wang, LR Chiarelli, ... ACS Medicinal Chemistry Letters 13 (4), 593-598, 2022 | 9 | 2022 |
| Targeting siderophore-mediated iron uptake in M. abscessus: a new strategy to limit the virulence of non-tuberculous mycobacteria M Mori, G Stelitano, G Cazzaniga, A Gelain, A Tresoldi, M Cocorullo, ... Pharmaceutics 15 (2), 502, 2023 | 6 | 2023 |
| Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex JC Sammartino, M Morici, G Stelitano, G Degiacomi, G Riccardi, ... Biochemical and Biophysical Research Communications 607, 49-53, 2022 | 6 | 2022 |
| Improving protection to prevent bacterial infections: preliminary applications of reverse vaccinology against the main cystic fibrosis pathogens M Cocorullo, LR Chiarelli, G Stelitano Vaccines 11 (7), 1221, 2023 | 2 | 2023 |
| Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity D Fan, B Wang, G Stelitano, K Savková, O Riabova, R Shi, X Wu, ... Biomedicines 11 (7), 1975, 2023 | 1 | 2023 |
| The veterinary anti-parasitic selamectin is a novel inhibitor of the mycobacterial DprE1 enzyme JM Ezquerra-Aznárez, G Degiacomi, H Gašparovič, G Stelitano, ... bioRxiv, 2021.12. 04.471217, 2021 | 1 | 2021 |
| Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus M Mori, M Cocorullo, A Tresoldi, G Cazzaniga, A Gelain, G Stelitano, ... European Journal of Medicinal Chemistry 265, 116073, 2024 | | 2024 |
| Benzothiozinone derivatives with anti-tubercular Activity− Further side chain investigation X Wu, W Wang, G Stelitano, O Riabova, B Wang, W Niu, M Cocorullo, ... European Journal of Medicinal Chemistry 264, 115976, 2024 | | 2024 |
